Sarepta Therapeutics
Price & Volume
Stats
See moreOpen | $17.13 |
Previous Close | $17.44 |
Day Range | $16.42-$17.23 |
52W Range | $14.68-$24.68 |
Market Cap | $1.8B |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $1.9B |
Revenue Growth (YoY) | -34.3% |
Gross Profit (12 Mos) | $377.2M |
Diluted EPS | -$1.57 |
News
See moreYahoo Finance • 3 days ago
Jim Cramer Makes a Contrarian Call on Chipotle (CMG)
Yahoo Finance • 3 days ago
Veeva Systems’ (VEEV) Comeback Gets Jim Cramer Talking
Yahoo Finance • 28 days ago
Oligonucleotide Therapeutics Market Outlook 2026-2035 - Featuring Profiles of Alnylam Pharmaceuticals, Ionis Pharmaceuticals, and Sarepta Therapeutics
Yahoo Finance • last month
Novartis drops 13% on trial failure, dragging Dyne and Sarepta
About
CEO | Dr. Michael E. Severino M.D. |
CFO | Mr. Ryan H. Wong |
Address | 215 First Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 835 |